The National Institutes of Health is suspending human testing of an experimental, taxpayer-funded, stem cell trial for heart failure in light of emerging questions about the scientific foundation for the treatment; Republicans are working to shift the national healthcare conversation by telling seniors their Medicare coverage may be in danger; the drive to tighten immigration rules is stirring concerns in the medical profession about how it will affect the future supply of doctors in the United States.
With the midterms a week away Republicans are working to shift the national healthcare conversation away from pre-existing conditions and health insurance by telling seniors their Medicare coverage may be in danger. According to Kaiser Health News, it's a technique used by both parties in different elections, although it is not clear if the attempt will work. Republicans charge that Democrats’ support for expanding Medicare would threaten the viability of the program for seniors who depend on it, but various fact-checkers have repeatedly challenged these claims.
The National Institutes of Health is suspending human testing of an experimental, taxpayer-funded, stem cell trial for heart failure in light of emerging questions about the scientific foundation for the treatment, The Washington Post reported. A years-long Harvard investigation uncovered “false and/or fabricated data” in 31 scientific papers from the laboratory of Piero Anversa, a researcher whose blockbuster findings raised hope there were stem cells in the heart that could repair damaged muscle. Anversa is not directly involved in the trial, but the heart stem cells he identified are being injected into the hearts of some of the patients.
The Republican drive to tighten immigration rules have stirred concerns in the medical profession about how it will affect the future supply of doctors in the United States, particularly in rural areas. Those are the same areas that tend to support President Donald Trump, Kaiser Health News reported. The American Medical Association said that 18% of practicing physicians and medical residents in patient care were born in other countries as of 2017. Foreign-born doctors are vital to the national health system, as the country is grappling with a doctor shortage that’s expected to grow to as many as 120,000 physicians by 2030, according to the Association of American Medical Colleges. Separately Tuesday, Trump said he was considering an executive order to ban birthright citizenship.
Safety and Efficacy Updates for Asthma and Urticaria Therapies
April 5th 2025The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and favorable hematological safety profile of remibrutinib, were highlighted at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More